Segment Reporting Practices of Select Indian and Global Pharmaceutical Companies: A Comparative Study

Authors

  • Anil Kumar Angrish
  • Lubhavani Sahu
  • Sanjeev Kumar Bansal

DOI:

https://doi.org/10.33516/rb.v49i4.115-130p

Keywords:

Segment reporting, Pharmaceutical Companies, Reportable Segment, Ind-AS 108, and Accounting Standard 17 (AS-17)

Abstract

Segment reporting is a financial reporting practice through which business entities disclose financial information about several business segments or divisions. It provides stakeholders with information on the performance and risks associated with each segment, helping them to have a better knowledge of the company’s entire operations. Segment reporting often entails identifying operational segments based on criteria such as products or services, geographic areas, or client categories. Revenues, costs, assets, liabilities, and other pertinent data associated with segments are reported. This disclosure assists investors, analysts, and other stakeholders in assessing the financial health and performance of a company’s various business segments. In this study, the geographic, business, and therapeutic segments of top 40 Indian pharmaceutical companies and top 10 global pharmaceutical companies have been analyzed to capture segment disclosures, as well as to identify similarities and differences in their segment reporting.

Downloads

Download data is not yet available.

Downloads

Published

2024-01-30

How to Cite

Angrish, A. K., Sahu, L., & Bansal, S. K. (2024). Segment Reporting Practices of Select Indian and Global Pharmaceutical Companies: A Comparative Study. Research Bulletin, 49(4), 113–128. https://doi.org/10.33516/rb.v49i4.115-130p

Issue

Volume 49, Issue 4, January 2024

Section

Articles
Crossref
Scopus
Google Scholar
Europe PMC

References

1. Annual Report of Department of Pharmaceuticals 2021-2022.

2. Annual Reports and Investor Presentations of the top 10 Global pharmaceutical companies for the year 2021-2022.

3. Annual Reports from official websites of top 40 listed Indian pharmaceutical companies for the year 2021–2022.

4. Bui, N.T. and Nguyen, P.T.T., 2019. Segment Report on Management Pharmaceutical Enterprises. Academy of Accounting and Financial Studies Journal, 23(6), pp.1-22.

5. https://dart.deloitte.com. 2023. [ONLINE] Available at: https://dart.deloitte.com/USDART/home/publications/roadmap/segment-reporting. [Accessed 30 April 2024].

6. Roy, G.G. and Das, B., 2019. Segment Reporting Practices in India: A Case Study of TCS. Emerging Economy Studies, 5(1), pp.55-62. DOI: https://doi.org/10.1177/2394901519825938

7. Shetiya, M.M. and Saraf, P. (2017). A Study of Segment Reporting Practice in India. International Education and Research Journal, 03(06). Available at: https://www.academia.edu/45200430/a_study_of_segment_reporting_practice_in_India

8. Shollapur, M.R. (no date). Segmental Disclosure By Wipro and Infosys. DIAS Technology Review. Vol. 01. Available at: https://dias.ac.in/wpcontent/uploads/2020/06/78-SegmentDisclosures-by-Wipro-Infosys.pdf.

9. www.fiercepharma.com. 2023. The top 20 pharma companies by 2022 revenue. [ONLINE] Available at: https://www.fiercepharma.com/pharma/top-20pharma-companies-2022-revenue. [Accessed 5 June 2023].

10. www.ibef.org. 2023. Indian Pharmaceutical Industry. [ONLINE] Available at: https://www.ibef.org/industry/pharmaceutical-india. [Accessed 15 June 2023].

11. www.investindia.gov.in. 2023. Invest India. [ONLINE] Available at: https://www.investindia.gov.in/sector/pharmaceuticals. [Accessed 18 May 2023].

12. www.mca.gov.in. 2023. Segment Reporting. [ONLINE] Available at: https://www.mca.gov.in/Ministry/notification/pdf/AS_17.pdf. [Accessed 27 May 2023].